Modeling-error robustness of a viral-load preconditioning strategy for HIV treatment switching

Proceedings of the 2010 American Control Conference, ACC 2010

Volumn , Issue , 2010, Pages 5155-5160

  Luo, Rutao ^a   Piovoso, Michael J ^b   Zurakowski, Ryan ^a  

^a UNIVERSITY OF DELAWARE   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BAYESIAN PARAMETER ESTIMATION; CLINICAL DATA; ERROR ROBUSTNESS; MODELING ERRORS; OPEN LOOPS; PARAMETER DEPENDENCY; PARAMETER DISTRIBUTIONS; PRE-CONDITIONING; VIRAL LOAD;

PARAMETER ESTIMATION;

EID: 77957760740     PISSN: None     EISSN: None     Source Type: Conference Proceeding    
DOI: None     Document Type: Conference Paper

References (26)

1. L. Perrin and A. Telenti, "Hiv treatment failure: testing for hiv resistance in clinical practice." Science, vol. 280, no. 5371, pp. 1871-1873, Jun 1998.
2. S. Bonhoeffer and M. A. Nowak, "Pre-existence and emergence of drug resistance in hiv-1 infection." Proc Biol Sci, vol. 264, no. 1382, pp. 631-637, May 1997. [Online]. Available: http://dx.doi.org/10.1098/rspb.1997. 0089.
3. D. Finzi, M. Hermankova, T. Pierson, L. M. Carruth, C. Buck, R. E. Chaisson, T. C. Quinn, K. Chadwick, J. Margolick, R. Brookmeyer, J. Gallant, M. Markowitz, D. D. Ho, D. D. Richman, and R. F. Siliciano, "Identification of a reservoir for hiv-1 in patients on highly active antiretroviral therapy." Science, vol. 278, no. 5341, pp. 1295-1300, Nov 1997.
4. S. Orsega, "Treatment of adult hiv infection: Antiretroviral update and overview," The Journal for Nurse Practitioners, vol. 3, no. 9, pp. 612-624, 2007.
5. M. S. Hirsch, F. Brun-Vzinet, R. T. D'Aquila, S. M. Hammer, V. A. Johnson, D. R. Kuritzkes, C. Loveday, J. W. Mellors, B. Clotet, B. Conway, L. M. Demeter, S. Vella, D. M. Jacobsen, and D. D. Richman, "Antiretroviral drug resistance testing in adult hiv-1 infection: recommendations of an international aids society-usa panel." JAMA, vol. 283, no. 18, pp. 2417-2426, May 2000.
6. M. S. Hirsch, F. Brun-Vzinet, B. Clotet, B. Conway, D. R. Kuritzkes, R. T. D'Aquila, L. M. Demeter, S. M. Hammer, V. A. Johnson, C. Loveday, J. W. Mellors, D. M. Jacobsen, and D. D. Richman, "Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an international aids society-usa panel." Clin Infect Dis, vol. 37, no. 1, pp. 113-128, Jul 2003.
7. M. S. Hirsch, H. F. Gnthard, J. M. Schapiro, F. Brun-Vzinet, B. Clotet, S. M. Hammer, V. A. Johnson, D. R. Kuritzkes, J. W. Mellors, D. Pillay, P. G. Yeni, D. M. Jacobsen, and D. D. Richman, "Antiretroviral drug resistance testing in adult hiv-1 infection: 2008 recommendations of an international aids society-usa panel." Clin Infect Dis, vol. 47, no. 2, pp. 266-285, Jul 2008. [Online]. Available: http://dx.doi.org/10.1086/589297.
8. W. F. Mangel, W. J. McGrath, M. T. Brown, M. L. Baniecki, D. L. Barnard, and Y. P. Pang, "A new form of antiviral combination therapy predicted to prevent resistance from arising, and a model system to test it." Curr Med Chem, vol. 8, no. 8, pp. 933-939, Jul 2001.
9. P. G. Yeni, S. M. Hammer, C. C. J. Carpenter, D. A. Cooper, M. A. Fischl, J. M. Gatell, B. G. Gazzard, M. S. Hirsch, D. M. Jacobsen, D. A. Katzenstein, J. S. G. Montaner, D. D. Richman, M. S. Saag, M. Schechter, R. T. Schooley, M. A. Thompson, S. Vella, and P. A. Volberding, "Antiretroviral treatment for adult hiv infection in 2002: updated recommendations of the international aids society-usa panel." JAMA, vol. 288, no. 2, pp. 222-235, Jul 2002.
10. P. G. Yeni, S. M. Hammer, M. S. Hirsch, M. S. Saag, M. Schechter, C. C. J. Carpenter, M. A. Fischl, J. M. Gatell, B. G. Gazzard, D. M. Jacobsen, D. A. Katzenstein, J. S. G. Montaner, D. D. Richman, R. T. Schooley, M. A. Thompson, S. Vella, and P. A. Volberding, "Treatment for adult hiv infection: 2004 recommendations of the international aids society-usa panel." JAMA, vol. 292, no. 2, pp. 251-265, Jul 2004. [Online]. Available: http://dx.doi.org/10. 1001/jama.292.2.251.
11. S. M. Hammer, M. S. Saag, M. Schechter, J. S. G. Montaner, R. T. Schooley, D. M. Jacobsen, M. A. Thompson, C. C. J. Carpenter, M. A. Fischl, B. G. Gazzard, J. M. Gatell, M. S. Hirsch, D. A. Katzenstein, D. D. Richman, S. Vella, P. G. Yeni, P. A. Volberding, and I. A. S.-U. panel, "Treatment for adult hiv infection: 2006 recommendations of the international aids society-usa panel." JAMA, vol. 296, no. 7, pp. 827-843, Aug 2006.
12. J. L. Martinez-Cajas and M. A. Wainberg, "Antiretroviral therapy : optimal sequencing of therapy to avoid resistance." Drugs, vol. 68, no. 1, pp. 43-72, 2008.
13. R. Zurakowski and D. Wodarz, "Treatment interruptions to decrease risk of resistance emerging during therapy switching in hiv treatment," Decision and Control, 2007 46th IEEE Conference on, pp. 5174 - 5179, Nov 2007.
14. R. Luo and R. Zurakowski, "A new strategy to decrease risk of resistance emerging during therapy switching in hiv treatment," in Proc. American Control Conference, 11-13 June 2008, pp. 2112-2117.
15. -, "Resistance risk management in hiv therapy switching with explicit quiescent t-cell modeling," in Proc. The International Federation of Automatic Control, 6-11 July 2008, pp. 10325-10330.
16. R. Luo, M. J. Piovoso, and R. Zurakowski, "A generalized multistrain model of hiv evolution with implications for drug-resistance management," American Control Conference, 2009. ACC '09., pp. 2295 - 2300, May 2009.
17. R. M. Ribeiro and S. Bonhoeffer, "Production of resistant hiv mutants during antiretroviral therapy." Proc Natl Acad Sci U S A, vol. 97, no. 14, pp. 7681-7686, Jul 2000.
18. L. Ruiz, J. Martinez-Picado, J. Romeu, R. Paredes, M. K. Zayat, S. Marfil, E. Negredo, G. Sirera, C. Tural, and B. Clotet, "Structured treatment interruption in chronically hiv-1 infected patients after long-term viral suppression," AIDS, vol. 14, no. 4, pp. 397-403, Mar 2000.
19. L. Ruiz, G. Carcelain, J. Martínez-Picado, S. Frost, S. Marfil, R. Paredes, J. Romeu, E. Ferrer, K. Morales-Lopetegi, B. Autran, and B. Clotet, "Hiv dynamics and t-cell immunity after three structured treatment interruptions in chronic hiv-1 infection," AIDS, vol. 15, no. 9, pp. F19-27, Jun 2001.
20. Y. Huang, D. Liu, and H. Wu, "Hierarchical bayesian methods for estimation of parameters in a longitudinal hiv dynamic system." Biometrics, vol. 62, no. 2, pp. 413-423, Jun 2006. [Online]. Available: http://dx.doi.org/05.00447.x.
21. X. Xia, "Estimation of hiv/aids parameters," Automatica, vol. 39, no. 11, pp. 1983-1988, 2003.
22. H. Wu, H. Zhu, H. Miao, and A. S. Perelson, "Parameter identifiability and estimation of hiv/aids dynamic models." Bull Math Biol, vol. 70, no. 3, pp. 785-799, Apr 2008. [Online]. Available: http://dx.doi.org/10.1007/s11538-007-9279-9.
23. D. G. M Davidian, Nonlinear models for repeated measures data. New York: Chapman and Hall, 1995.
24. H. W. Yangxin Huang, Dacheng Liu, "Hierarchical bayesian methods for estimation of parameters in a longitudinal hiv dynamic system," Department of Biostatistics & Computational Biology, University of Rochester School of Medicine and Dentistry, Tech. Rep., July 2004.
25. P. on Antiretroviral Guidelines for Adults and Adolescents., Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents., Department of Health and Human Services. Std., November 2008. [Online]. Available: http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf.
26. S. Sungkanuparph, T. Anekthananon, N. Hiransuthikul, C. Bowonwatanuwong, K. Supparatpinyo, P. Mootsikapun, P. Chetchotisakd, S. Kiertiburanakul, S. Tansuphaswadikul, W. Buppanharun, W. Manosuthi, W. Techasathit, W. Ratanasuwan, W. Tantisiriwat, S. Suwanagool, M. Leechawengwongs, K. Ruxrungtham, and T. A. Society, "Guidelines for antiretroviral therapy in hiv-1 infected adults and adolescents: the recommendations of the thai aids society (tas) 2008." J Med Assoc Thai, vol. 91, no. 12, pp. 1925-1935, Dec 2008.